{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:51:18Z","timestamp":1792759878692,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T00:00:00Z","timestamp":1318291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Rare diseases (RD) are characterized by low prevalence and affect not more than five individuals per 10,000 in the European population; they are a large and heterogeneous group of disorders including more than 7,000 conditions and often involve all organs and tissues, with several clinical subtypes within the same disease. Very often information concerning either diagnosis and\/or prognosis on many RD is insufficient. microRNAs are a class of small non-coding RNAs that regulate gene expression at the posttranscriptional level by either degrading or blocking translation of messenger RNA targets. Recently, microRNA expression patterns of body fluids underscored their potential as noninvasive biomarkers for various diseases. The role of microRNAs as potential biomarkers has become particularly attractive. The identification of disease-related microRNAs is essential for understanding the pathogenesis of diseases at the molecular level, and is critical for designing specific molecular tools for diagnosis, treatment and prevention. Computational analysis of microRNA-disease associations is an important complementary means for prioritizing microRNAs for further experimental examination. In this article, we explored the added value of miRs as biomarkers in a selected panel of RD hitting different tissues\/systems at different life stages, but sharing the need of better biomarkers for diagnostic and prognostic purposes.<\/jats:p>","DOI":"10.3390\/ijms12106733","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T12:52:32Z","timestamp":1318337552000},"page":"6733-6742","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Role of microRNAs in the Biology of Rare Diseases"],"prefix":"10.3390","volume":"12","author":[{"given":"Marco","family":"Salvatore","sequence":"first","affiliation":[{"name":"National Centre for Rare Diseases, Istituto Superiore di Sanit\u00e0 Viale Regina Elena, Rome 299-00161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5036-3710","authenticated-orcid":false,"given":"Armando","family":"Magrelli","sequence":"additional","affiliation":[{"name":"National Centre for Rare Diseases, Istituto Superiore di Sanit\u00e0 Viale Regina Elena, Rome 299-00161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Taruscio","sequence":"additional","affiliation":[{"name":"National Centre for Rare Diseases, Istituto Superiore di Sanit\u00e0 Viale Regina Elena, Rome 299-00161, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2011,10,11]]},"reference":[{"key":"ref_1","unstructured":"(2000). Regulation (EC) 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. Off J Eur Communities, 22, L18:1\u2013L18:5."},{"key":"ref_2","unstructured":"Available online: http:\/\/archive.eurordis.org\/article.php3?id_article=454."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/472017a","article-title":"Rare-disease project has global ambitions","volume":"472","author":"Abbott","year":"2011","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1101\/gr.6406307","article-title":"Raising the estimate of functional human sequences","volume":"17","author":"Pheasant","year":"2007","journal-title":"Genome Res"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.mt.6300311","article-title":"MicroRNAs in disease and potential therapeutic applications","volume":"15","author":"Soifer","year":"2007","journal-title":"Mol. Ther"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"MicroRNAs in cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu. Rev. Med"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ceb.2009.03.002","article-title":"MicroRNAs and cancer\u2013new paradigms in molecular oncology","volume":"21","author":"Negrini","year":"2009","journal-title":"Curr. Opin. Cell Biol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/cc.7.17.6597","article-title":"Mechanisms of microRNA deregulation in human cancer","volume":"7","author":"Deng","year":"2008","journal-title":"Cell Cycle"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"de la Chapelle, A, and Jazdzewski, K (2011). MicroRNAs in thyroid cancer. J Clin Endocrinol Metab.","DOI":"10.1210\/jc.2011-1004"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa074256","article-title":"MicroRNA expression in cytogenetically normal acute myeloid leukemia","volume":"358","author":"Marcucci","year":"2008","journal-title":"N. Engl. J. Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1399-0004.2008.01134.x","article-title":"Noncoding RNAs in mental retardation","volume":"75","author":"Szulwach","year":"2009","journal-title":"Clin. Genet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1399-0004.2010.01370.x","article-title":"microRNAs in diseases: From candidate to modifier genes","volume":"77","author":"Bandiera","year":"2010","journal-title":"Clin. Genet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4161\/rna.6.4.8830","article-title":"Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes","volume":"6","author":"Duan","year":"2009","journal-title":"RNA Biol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.cell.2011.02.016","article-title":"Interactome networks and human disease","volume":"144","author":"Vidal","year":"2011","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Mizuno, H, Nakamura, A, Aoki, Y, Ito, N, Kishi, S, Yamamoto, K, Sekiguchi, M, Takeda, S, and Hashido, K (2011). Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One, 6.","DOI":"10.1371\/journal.pone.0018388"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/ncb1373","article-title":"The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation","volume":"8","author":"Naguibneva","year":"2006","journal-title":"Nat. Cell Biol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ng1725","article-title":"The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation","volume":"38","author":"Chen","year":"2006","journal-title":"Nat. Genet"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2010.07.008","article-title":"MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin\/nNOS pathway","volume":"12","author":"Cacchiarelli","year":"2010","journal-title":"Cell Metab"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13027","DOI":"10.1073\/pnas.0805038105","article-title":"Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis","volume":"105","author":"Sutherland","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.0708115104","article-title":"Distinctive patterns of microRNA expression in primary muscular disorders","volume":"104","author":"Eisenberg","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1096\/fj.08-128579","article-title":"Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia","volume":"23","author":"Greco","year":"2009","journal-title":"FASEB J"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1247\/csf.08022","article-title":"MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy","volume":"33","author":"Yuasa","year":"2008","journal-title":"Cell Struct. Funct"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1126\/science.1181046","article-title":"MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice","volume":"326","author":"Williams","year":"2009","journal-title":"Science"},{"key":"ref_27","unstructured":"Swerdlow, SH, Campo, E, Harris, NL, Jaffe, ES, Pileri, SA, Stein, H, Thiele, J, and Vardiman, JW (2008). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, International Agency for Research on Cancer Press. [4th ed]."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1182\/blood-2009-12-256719","article-title":"MicroRNA expression in Sezary syndrome: Identification, function, and diagnostic potential","volume":"116","author":"Ballabio","year":"2010","journal-title":"Blood"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1038\/cddis.2011.32","article-title":"MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in S\u00e9zary syndrome","volume":"2","author":"Narducci","year":"2011","journal-title":"Cell Death Dis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/jid.2010.349","article-title":"MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in S\u00e9zary syndrome","volume":"131","author":"Qin","year":"2011","journal-title":"J. Invest. Dermatol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4161\/epi.5.7.13055","article-title":"Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome","volume":"5","author":"Urdinguio","year":"2010","journal-title":"Epigenetics"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1399-0004.2010.01490.x","article-title":"MicroRNA profiling of multiple osteochondromas: Identification of disease-specific and normal cartilage signatures","volume":"78","author":"Zuntini","year":"2010","journal-title":"Clin. Genet"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/jid.2011.55","article-title":"MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2","volume":"131","author":"Xu","year":"2011","journal-title":"J. Invest. Dermatol"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/0008-5472.CAN-10-1031","article-title":"miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation","volume":"71","author":"Sun","year":"2011","journal-title":"Cancer Res"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbrc.2010.12.055","article-title":"miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras","volume":"404","author":"Shin","year":"2011","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1158\/0008-5472.CAN-06-4478","article-title":"Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia","volume":"67","author":"Landais","year":"2007","journal-title":"Cancer Res"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2009.09500.x","article-title":"Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease","volume":"162","author":"Cialfi","year":"2010","journal-title":"Br. J. Dermatol"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Manca, S, Magrelli, A, Cialfi, S, Lefort, K, Ambra, R, Alimandi, M, Biolcati, G, Uccelletti, D, Palleschi, C, and Screpanti, I (2011). Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Exp Dermatol.","DOI":"10.1111\/j.1600-0625.2011.01359.x"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","article-title":"Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock","volume":"179","author":"Tili","year":"2007","journal-title":"J. Immunol"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1593\/tlo.09124","article-title":"Altered microRNA expression patterns in hepatoblastoma patients","volume":"2","author":"Magrelli","year":"2009","journal-title":"Transl. Oncol"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24125","article-title":"MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma","volume":"53","author":"Pagel","year":"2011","journal-title":"Hepatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/12\/10\/6733\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:57:38Z","timestamp":1760219858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/12\/10\/6733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,11]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2011,10]]}},"alternative-id":["ijms12106733"],"URL":"https:\/\/doi.org\/10.3390\/ijms12106733","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,11]]}}}